Teladoc (TDOC) Tops Q4 EPS by 5c, guidance misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Teladoc (TDOC) beats FQ4 earnings expectations but guidance falls short; shares slide
February 20, 2024 4:21 PM ESTShares of Teladoc Health (NYSE: TDOC) fell over 11% following the closing bell on Tuesday after the companys FQ4 revenue and FQ1 2024 guidance fell short of expectations.
The healthcare firm reported a loss per share of $0.17 for the quarter, compared to a loss per share of $0.22 expected by analysts. However, revenue came in at $660.53 million, missing the consensus estimate... More
